BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 4216519)

  • 1. [Liver biopsy studies in long-term therapy of psoriasis using methotrexate].
    Dietz O; Pachaly A; Schillat I
    Dermatol Monatsschr; 1974 Aug; 160(8):634-42. PubMed ID: 4216519
    [No Abstract]   [Full Text] [Related]  

  • 2. Hepatotoxicity of methotrexate in the treatment of psoriasis.
    Palmer HM
    Practitioner; 1973 Sep; 211(263):324-8. PubMed ID: 4759241
    [No Abstract]   [Full Text] [Related]  

  • 3. Hepatotoxicity of long-term methotrexate therapy for psoriasis.
    Tobias H; Auerbach R
    Arch Intern Med; 1973 Sep; 132(3):391-6. PubMed ID: 4783020
    [No Abstract]   [Full Text] [Related]  

  • 4. Liver biopsies upsilon liver scans in methotrexate-treated patients with psoriasis.
    Geronemus RG; Auerbach R; Tobias H
    Arch Dermatol; 1982 Sep; 118(9):649-51. PubMed ID: 7114866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver disease in psoriatics--An effect of methotrexate therapy?
    Shapiro HA; Trowbridge JO; Lee JC; Maibach HI
    Arch Dermatol; 1974 Oct; 110(4):547-51. PubMed ID: 4414499
    [No Abstract]   [Full Text] [Related]  

  • 6. [Incidence of liver diseases in psoriatic patients with special reference to methotrexate therapy].
    Moldenhauer E; Dabels J; Diwok K; Leithäuser W; Nowotny P
    Dermatol Monatsschr; 1973 Mar; 159(3):242-8. PubMed ID: 4704945
    [No Abstract]   [Full Text] [Related]  

  • 7. Ultrasound as a screening procedure for methotrexate-induced hepatic damage in severe psoriasis.
    Miller JA; Dodd H; Rustin MH; Lees WR; Levene GM; Kirby JD; Munro DD
    Br J Dermatol; 1985 Dec; 113(6):699-705. PubMed ID: 3913457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver biopsy in methotrexate treatment.
    Zachariae H; Schiodt T
    Acta Derm Venereol; 1971; 51(3):215-20. PubMed ID: 4103033
    [No Abstract]   [Full Text] [Related]  

  • 9. Methotrexate maintenance therapy and liver damage in psoriasis.
    van de Kerkhof PC; Hoefnagels WH; van Haelst UJ; Mali JW
    Clin Exp Dermatol; 1985 May; 10(3):194-200. PubMed ID: 4006282
    [No Abstract]   [Full Text] [Related]  

  • 10. Liver injury associated with methotrexate therapy for psoriasis.
    Podurgiel BJ; McGill DB; Ludwig J; Taylor WF; Muller SA
    Mayo Clin Proc; 1973 Nov; 48(11):787-92. PubMed ID: 4758150
    [No Abstract]   [Full Text] [Related]  

  • 11. Changes in liver histology during methotrexate therapy of psoriasis correlated to the concentration of methotrexate and folate in erythrocytes.
    Hendel J; Poulsen H; Nyfors B; Nyfors A
    Acta Pharmacol Toxicol (Copenh); 1985 Apr; 56(4):321-6. PubMed ID: 4024960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Liver damage in methotrexate-treated patients. When liver biopsy is necessary in the follow-up?].
    Nieminen U; Höök-Nikanne J; Kärkkäinen P; Niemelä S
    Duodecim; 2005; 121(24):2680-8. PubMed ID: 16454249
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluation of possible chronic hepatotoxicity from methotrexate for psoriasis.
    Weinstein GD; Cox JW; Suringa DW; Millard MM; Kalser M; Frost P
    Arch Dermatol; 1970 Dec; 102(6):613-8. PubMed ID: 5501902
    [No Abstract]   [Full Text] [Related]  

  • 14. [Laboratory and oligobiopsy examination of the liver in patients with psoriasis treated with methotrexate (preliminary report)].
    Ruszczak Z; Prószyńska-Kuczyńska W; Babiński S; Biernat S; Kulig A
    Przegl Dermatol; 1974; 61(6):803-7. PubMed ID: 4431967
    [No Abstract]   [Full Text] [Related]  

  • 15. Replacement of routine liver biopsy by procollagen III aminopeptide for monitoring patients with psoriasis receiving long-term methotrexate: a multicentre audit and health economic analysis.
    Chalmers RJ; Kirby B; Smith A; Burrows P; Little R; Horan M; Hextall JM; Smith CH; Klaber M; Rogers S
    Br J Dermatol; 2005 Mar; 152(3):444-50. PubMed ID: 15787812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reliability of the Roenigk classification of liver damage after methotrexate treatment for psoriasis: a clinicopathologic study of 160 liver biopsy specimens.
    Berends MA; van Oijen MG; Snoek J; van de Kerkhof PC; Drenth JP; Han van Krieken J; de Jong EM
    Arch Dermatol; 2007 Dec; 143(12):1515-9. PubMed ID: 18087000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver biopsy in methotrexate-treated psoriatics-a re-evalution.
    Zachariae H; Grunnet E; Sogaard H
    Acta Derm Venereol; 1975; 55(4):291-6. PubMed ID: 52258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longterm methotrexate therapy in rheumatoid arthritis: a review.
    Kremer JM
    J Rheumatol Suppl; 1985 Dec; 12 Suppl 12():25-8. PubMed ID: 3913773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of liver function using fasting bile salt concentrations in psoriasis prior to and during methotrexate therapy.
    Lawrence CM; Strange RC; Summerly R; Scriven AJ; Elmahallawy M; Wood A; Fletcher PJ; Beckett GJ
    Clin Chim Acta; 1983 Apr; 129(3):341-51. PubMed ID: 6851172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary and hepatic complications of methotrexate therapy of psoriasis.
    Filip DJ; Logue GL; Harle TS; Farrar WH
    JAMA; 1971 May; 216(5):881-2. PubMed ID: 5108291
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.